Goldman Sachs’s Strongbridge Biopharma plc. SBBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-196,365
| Closed | -$400K | – | 5877 |
|
|
2021
Q3 | $400K | Sell |
196,365
-205,932
| -51% | -$419K | ﹤0.01% | 4508 |
|
|
2021
Q2 | $1.2M | Buy |
402,297
+360,299
| +858% | +$1.07M | ﹤0.01% | 3893 |
|
|
2021
Q1 | $116K | Buy |
41,998
+18,975
| +82% | +$52.4K | ﹤0.01% | 4994 |
|
|
2020
Q4 | $56K | Sell |
23,023
-9,280
| -29% | -$22.6K | ﹤0.01% | 4547 |
|
|
2020
Q3 | $68K | Buy |
32,303
+294
| +0.9% | +$619 | ﹤0.01% | 4286 |
|
|
2020
Q2 | $121K | Buy |
32,009
+7,243
| +29% | +$27.4K | ﹤0.01% | 4135 |
|
|
2020
Q1 | $47K | Sell |
24,766
-9,474
| -28% | -$18K | ﹤0.01% | 4288 |
|
|
2019
Q4 | $71K | Buy |
34,240
+4,814
| +16% | +$9.98K | ﹤0.01% | 4175 |
|
|
2019
Q3 | $70K | Buy |
29,426
+1,387
| +5% | +$3.3K | ﹤0.01% | 4091 |
|
|
2019
Q2 | $88K | Sell |
28,039
-68,303
| -71% | -$214K | ﹤0.01% | 4017 |
|
|
2019
Q1 | $480K | Buy |
96,342
+77,004
| +398% | +$384K | ﹤0.01% | 3572 |
|
|
2018
Q4 | $87K | Sell |
19,338
-102,249
| -84% | -$460K | ﹤0.01% | 3908 |
|
|
2018
Q3 | $590K | Sell |
121,587
-266,808
| -69% | -$1.29M | ﹤0.01% | 3396 |
|
|
2018
Q2 | $2.33M | Buy |
388,395
+357,643
| +1,163% | +$2.15M | ﹤0.01% | 2823 |
|
|
2018
Q1 | $272K | Sell |
30,752
-6,793
| -18% | -$60.1K | ﹤0.01% | 3731 |
|
|
2017
Q4 | $272K | Buy |
+37,545
| New | +$272K | ﹤0.01% | 3693 |
|